MaxCyte, Inc. (MXCT) Misses Q2 EPS by 2c

MaxCyte, Inc. (NASDAQ: MXCT) reported Q2 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $8.5 million versus the consensus estimate of $9.63 million.

For earnings history and earnings-related data on MaxCyte, Inc. (MXCT) click here.

You May Also Be Interested In

• Trump Did Not Repeat Termination Of Interim Deal With Iran During Nato Summit, Source Familiar With The Talks Says - Reuters
• DigitalOcean (DOCN) Reiterated at Overweight by Cantor Fitzgerald on Q2 Pre-Announcement
• RoboStrategy reports NAV jump and $7.6M in private placements